Fresenius Medical Care Corporation (NYSE: FMS) and The Joint Corp. (NASDAQ:JYNT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Volatility and Risk

Fresenius Medical Care Corporation has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, The Joint Corp. has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

Dividends

Fresenius Medical Care Corporation pays an annual dividend of $0.37 per share and has a dividend yield of 0.8%. The Joint Corp. does not pay a dividend. Fresenius Medical Care Corporation pays out 17.0% of its earnings in the form of a dividend.

Insider and Institutional Ownership

2.6% of Fresenius Medical Care Corporation shares are owned by institutional investors. Comparatively, 47.0% of The Joint Corp. shares are owned by institutional investors. 6.1% of The Joint Corp. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Fresenius Medical Care Corporation and The Joint Corp.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fresenius Medical Care Corporation 7.06% 11.57% 4.97%
The Joint Corp. -48.08% -103.25% -42.06%

Earnings & Valuation

This table compares Fresenius Medical Care Corporation and The Joint Corp.’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Fresenius Medical Care Corporation $20.61 billion 1.43 $3.76 billion $2.18 22.01
The Joint Corp. $22.97 million 2.67 -$4.53 million ($0.87) -5.34

Fresenius Medical Care Corporation has higher revenue and earnings than The Joint Corp.. The Joint Corp. is trading at a lower price-to-earnings ratio than Fresenius Medical Care Corporation, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Fresenius Medical Care Corporation and The Joint Corp., as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care Corporation 0 3 6 0 2.67
The Joint Corp. 0 0 4 0 3.00

Fresenius Medical Care Corporation presently has a consensus target price of $46.00, suggesting a potential downside of 4.15%. The Joint Corp. has a consensus target price of $6.15, suggesting a potential upside of 32.26%. Given The Joint Corp.’s stronger consensus rating and higher probable upside, analysts plainly believe The Joint Corp. is more favorable than Fresenius Medical Care Corporation.

Summary

Fresenius Medical Care Corporation beats The Joint Corp. on 8 of the 15 factors compared between the two stocks.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company’s Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.